Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Edmond F. O'Donnell"'
Autor:
Mark F. Megerian, Edmond F. O'Donnell, Augustine M. Saiz, Ellen P. Fitzpatrick, Mark A. Lee, Gillian L.S. Soles, Sean T. Campbell
Publikováno v:
Trauma Case Reports, Vol 45, Iss , Pp 100836- (2023)
Case report: Traumatic hip dislocations require prompt diagnosis and reduction to preserve the native joint. The classic irreducible posterior hip fracture-dislocation has been described as an immobile, slightly flexed, and internally rotated hip on
Externí odkaz:
https://doaj.org/article/09cc9dfb5daf48cda0a93aa8b548d763
Autor:
Hyo Sang Jang, Martin Pearce, Edmond F. O’Donnell, Bach Duc Nguyen, Lisa Truong, Monica J. Mueller, William H. Bisson, Nancy I. Kerkvliet, Robert L. Tanguay, Siva Kumar Kolluri
Publikováno v:
Biology, Vol 6, Iss 4, p 41 (2017)
We previously reported that raloxifene, an estrogen receptor modulator, is also a ligand for the aryl hydrocarbon receptor (AhR). Raloxifene induces apoptosis in estrogen receptor-negative human cancer cells through the AhR. We performed structure–
Externí odkaz:
https://doaj.org/article/44116b87b9764194819540210e933587
Autor:
Muhammad Umar Jawad, Brad H. Pollock, Lauren N. Zeitlinger, Edmond F. O'Donnell, Sophia A. Traven, Janai R. Carr‐Ascher, Elysia Alvarez, Marcio H. Malogolowkin, Steven W. Thorpe, R. Lor Randall
Publikováno v:
Journal of Surgical Oncology. 126:577-587
The ideal local treatment modality for pelvic and sacral Ewing sarcoma (EWS) is controversial.We present the data from the American College of Surgeon's National Cancer Database (NCDB) and the National Cancer Institute's Surveillance, Epidemiology an
Autor:
Muhammad Umar Jawad, Brad H. Pollock, Lauren N. Zeitlinger, Edmond F. O'Donnell, Sophia A. Traven, Janai R. Carr‐Ascher, Elysia Alvarez, Marcio H. Malogolowkin, Steven W. Thorpe, R. Lor Randall
Publikováno v:
Journal of Surgical Oncology. 126
Autor:
Hyo Sang Jang, Nancy I. Kerkvliet, Edmond F. O’Donnell, Siva Kumar Kolluri, Daniel F Liefwalker
Publikováno v:
Apoptosis. 26:307-322
The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor and a member of the bHLH/PAS (basic Helix-Loop-Helix/Per-Arnt-Sim) family of proteins. The AhR was cloned and characterized for its role in mediating the toxicity of dioxi
Autor:
Muhammad Umar Jawad, Lauren N. Zeitlinger, Arnaud F. Bewley, Edmond F. O’Donnell, Sophia A. Traven, Janai R. Carr-Ascher, Arta M. Monjazeb, Robert J. Canter, Steven W. Thorpe, R. Lor Randall
Publikováno v:
Journal of clinical medicine, vol 11, iss 18
Journal of Clinical Medicine; Volume 11; Issue 18; Pages: 5475
Journal of Clinical Medicine; Volume 11; Issue 18; Pages: 5475
Background: Cutaneous soft-tissue sarcoma (CSTS) of the head and neck are rare and are known to have aggressive clinical course. The current study utilizes a population-based registry in the U.S. to characterize these malignancies and explore dispari
Publikováno v:
Clinical Cancer Research. 28:A022-A022
Soft tissue sarcomas (STS) are rare tumors encompassing over 70 distinct histopathological subtypes that share a common treatment strategy comprising surgical resection, radiation, and chemotherapy in certain situations. Disease progression and failu
Autor:
Daniel F Liefwalker, Hyo Sang Jang, Nancy I. Kerkvliet, Siva Kumar Kolluri, Edmond F. O’Donnell
Background: The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor and a member of the bHLH/PAS (basic Helix-Loop-Helix/Per-Arnt-Sim) family of proteins. The AhR was cloned and characterized for its role in mediating the toxic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbc063e3536238c66455e6ae9bf10178
https://doi.org/10.21203/rs.3.rs-131951/v1
https://doi.org/10.21203/rs.3.rs-131951/v1
Autor:
Steve W Thorpe, William J. Murphy, Ian R. Sturgill, Kevin Stoffel, Alicia A. Gingrich, Sean J. Judge, Logan V Vick, Robert J. Canter, Yue Lyu, May Cho, Robert B. Rebhun, Edmond F O'Donnell, Cordelia Dunai, Alyssa Bellini, Arta M. Monjazeb, Shuai Chen, Morgan A. Darrow
Publikováno v:
Journal for immunotherapy of cancer, vol 8, iss 2
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for Immunotherapy of Cancer
PurposeGiven the unmet need for novel immunotherapy in soft tissue sarcoma (STS), we sought to characterize the phenotype and function of intratumoral natural killer (NK) and T cells to identify novel strategies to augment tumor-infiltrating lymphocy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffbb80badea9765fcd14c1db9a8b34fb
https://escholarship.org/uc/item/3k92s282
https://escholarship.org/uc/item/3k92s282
Autor:
Yue Lyu, Robert B. Rebhun, Ian R. Sturgill, Cordelia Dunai, May Cho, Kevin Stoffel, Morgan A. Darrow, Alyssa Bellini, Alicia A. Gingrich, Logan V Vick, Arta M. Monjazeb, William J. Murphy, Sean J. Judge, Edmond F O'Donnell, Robert J. Canter, Steven W. Thorpe, Shuai Chen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Although the presence and activity of tumor infiltrating lymphocytes (TILs) have been shown to be important factors for survival and response to immunotherapy for multiple cancer types, the benefits of immunotherapy in soft tissue sarcomas